Breaking the Silence Around Screening
A simple, free, and at-home test can help detect this type of cancer at the earliest possible stage. The Institut régional fédératif du cancer de Franche-Comté (IRFC) is launching a direct communication campaign to raise awareness.
Colorectal Cancer Screening: A Major Public Health Issue
Also known as colon and rectal cancer, this cancer is one of the most common in France. More than 47,500 people are diagnosed each year, resulting in nearly 17,000 deaths (figures from the Institut National du Cancer for 2022). In 80% of cases, the cancer originates from a benign tumor that slowly develops into a cancerous one. Early detection is crucial for improving outcomes, making screening efforts vital for public health.
In 2023, the disease affected 26,212 men and 21,370 women, with median ages of 71 and 72 years, respectively. The 17,000 deaths were more common among men (8,977) than women (7,998). The mortality rate decreased by 2% in men and 1.5% in women between 2012 and 2022.
Colorectal cancer is the third most common cancer in men, after prostate and lung cancer, accounting for 11.2% of all new male cancer cases. In women, it is the second most common cancer after breast cancer (11.3% of all new female cancer cases). This cancer is the second leading cause of cancer death in France, representing nearly 12% of all cancer deaths, particularly in those aged 65 and older. However, mortality has been steadily declining since 1980, potentially linked to increased access to screening and removal of precancerous lesions.
Early Detection Leads to Cure in 9 Out of 10 Cases
Screening primarily targets women and men between the ages of 50 and 74. They are invited to complete an immunological test every two years. This involves performing a stool sample test at home. The test is available free of charge from your primary care physician, pharmacist, or gastroenterologist, and can also be ordered online.
Meeting the Public
Despite its effectiveness, screening is only performed by one in three eligible individuals. Throughout March, the gastroenterology teams at the CHU Besançon Franche-Comté have been meeting with the public during the “Blue Tuesdays” on March 10, 24, and 31.
Following a visit to Super U de l’Amitié on March 10, the gastroenterology teams will be at the Carrefour in Chalezeule on March 24 from 9 a.m. To 1 p.m. And at the Galerie Châteaufarine on March 31 from 9 a.m. To 1 p.m. These events offer an opportunity to speak with healthcare professionals and receive accurate information about screening. Simultaneously, Pierre Fabre Laboratories is partnering with the CHU Besançon Franche-Comté by featuring artist Jordane Saget, who has created a mural composed of “lines of life” in the Jean Minjoz hospital hall.
